Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

542
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
542
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

174
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
174
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

249
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
249
Censoring Survival Data01:09

Censoring Survival Data

193
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
193
Hazard Rate01:11

Hazard Rate

164
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
164
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

342
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
342

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

International urology and nephrology·2014
Same author

Simple whole-cell biodetection and bioremediation of heavy metals based on an engineered lead-specific operon.

Environmental science & technology·2014
Same author

The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1.

European journal of pharmacology·2014
Same author

The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology.

Journal of ethnopharmacology·2014
Same author

Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.

Arteriosclerosis, thrombosis, and vascular biology·2014
Same author

Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

International journal of cardiology·2014

Related Experiment Video

Updated: Aug 22, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Semiparametric copula-based regression modeling of semi-competing risks data.

Hong Zhu1, Yu Lan2, Jing Ning3

  • 1Division of Biostatistics, Department of Population and Data Sciences, The University of Texas Southwestern Medical Center, Dallas, Texas 75390.

Communications in Statistics: Theory and Methods
|November 10, 2022
PubMed
Summary

This study introduces a new statistical model for analyzing medical data with semi-competing risks, like cancer recurrence and death. The method effectively models time-varying effects and the relationship between these events.

Keywords:
Copula modeldependent censoringnonlinear estimating equationpseudo-likelihoodsemi-competing risks

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

346

Related Experiment Videos

Last Updated: Aug 22, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

346

Area of Science:

  • Biostatistics
  • Medical Statistics
  • Survival Analysis

Background:

  • Semi-competing risks data are common in medical research, where one event can be censored by another but not prevent it.
  • Analyzing these data requires specialized regression models to account for the complex event relationships.

Purpose of the Study:

  • To develop a flexible regression framework for semi-competing risks data.
  • To assess covariate effects on both non-terminal and terminal event times.
  • To model the dependence between non-terminal and terminal events using a copula approach.

Main Methods:

  • Proposed a copula-based regression framework for semi-competing risks.
  • Incorporated time-varying coefficients to capture dynamic covariate effects.
  • Developed a two-stage inferential procedure for parameter estimation.
  • Utilized simulation studies to evaluate finite sample performance.

Main Results:

  • The proposed method effectively estimates association parameters and time-varying regression coefficients.
  • Simulation studies demonstrated the method's good finite sample performance.
  • The approach was successfully applied to real-world data from elderly women with early-stage breast cancer.

Conclusions:

  • The copula-based regression model provides a robust approach for analyzing semi-competing risks data.
  • The method allows for the assessment of time-varying covariate effects and event dependencies.
  • This framework enhances the understanding of disease progression and outcomes in complex medical scenarios.